Meyers James R
SEC insider (Form 3/4/5 filer). CIK 0001387521. Director at CytomX Therapeutics, Inc. (CTMX) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Meyers James R has filed insider reports for
- CytomX Therapeutics, Inc. (CTMX): Director
- Vera Therapeutics, Inc. (VERA): Director
- SANGAMO THERAPEUTICS, INC (SGMO): Director
Meyers James R
CIK: 0001387521
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 17, 2026CTMX
CytomX Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
59K shares- - May 21, 2026VERA
Vera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.1K shares- - Nov 25, 2025VERA
Vera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Jun 12, 2025SGMO
SANGAMO THERAPEUTICS, INC
AwardDirect25K shares- - Jun 11, 2025CTMX
CytomX Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
38K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  CTMX CytomX Therapeutics, Inc. | Award Stock Option (Right to Buy) | 59,000 | - | - | Direct |
| May 21, 2026 |  VERA Vera Therapeutics, Inc. | Award Stock Option (right to buy) | 17,084 | - | - | Direct |
| Nov 25, 2025 | VERA Vera Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Jun 12, 2025 |  SGMO SANGAMO THERAPEUTICS, INC | Award | 25,000 | - | - | Direct |
| Jun 11, 2025 | CTMX CytomX Therapeutics, Inc. | Award Stock Option (Right to Buy) | 38,000 | - | - | Direct |
1-5 of 5 transactions